Filing Details

Accession Number:
0001209191-18-054894
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-12 16:38:26
Reporting Period:
2018-10-11
Accepted Time:
2018-10-12 16:38:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Miragen Therapeutics Inc. MGEN Services-Medical Laboratories (8071) 471187261
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611048 E. Thomas Hughes C/o Miragen Therapeutics, Inc.
6200 Lookout Road
Boulder CO 80301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-11 10,000 $4.77 12,827 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.67 to $4.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.